Xealth, a digital health startup focused on improving connections between patients and providers, announced Tuesday that Trinity Health invested an undisclosed amount in the company, raising its Series B funding haul to $25 million.
Trinity is the 15th health system to invest in Xealth. Advocate Aurora Enterprises, Banner Health, ChristianaCare, Cone Health, Novant Health and Stanford Health Care are among other notable health systems participating in Xealth’s Series B funding round.
The Livonia, Michigan-based provider invested in Xealth instead of competitors like Redox or Validic because it offers a more comprehensive solution for providers, Marcus Shipley, chief innovation and information officer for Trinity Health, said in an interview.
“It scales very well,” he said.
Xealth’s solution also has the potential to improve traditional healthcare delivery because it integrates into a providers’ electronic health record instead of working independently like other digital health products.
“It’s going to bring the two together,” Shipley said.
Trinity plans to make similar investments in the future, as it’s just getting its innovation fund off the ground. It invested in Trueveta, a provider-led health data analytics company, in February. But its other investments haven’t been made public.
The health system wants to invest in companies that can improve clinical workflows, patient experience, financial outcomes and offer a solid return on investment, Shipley said.
“That’s the combination we’re looking for,” he said.
Xealth promises to make it easier for providers to integrate digital health into their clinical workflows, claiming to lower integration and deployment costs by up to 80%.
The company has raised a total of nearly $54 billion from Providence, Cleveland Clinic, Cerner, LRV Health, Threshold Ventures, McKesson Ventures, Novartis and other investors.
The $24 billion raised by Xealth in the third quarter was the most in the ePrescriber category, according to new data from Digital Health Business & Technology.